antithrombotic


Also found in: Dictionary.

antithrombotic

 [an″te-throm-bot´ik]
1. preventing or interfering with the formation of thrombi.
2. an agent that has this effect, such as heparin or coumarin. See also anticoagulant and thrombolytic.

antithrombotic

/an·ti·throm·bot·ic/ (-throm-bot´ik)
1. preventing or interfering with the formation of thrombi.
2. an agent that so acts.

antithrombotic

[-thrombot′ik]
preventing or interfering with the formation of a thrombus or blood clotting.

antithrombotic

adjective Referring to an agent or effect that prevents or reduces thrombosis.
 
noun An agent that prevents or interferes with thrombosis; e.g., thrombolytic.

antithrombotic

Hematology adjective Referring to an agent or effect that prevents or reduces thrombosis noun An agent that prevents or interferes with thrombosis. See Heparin, Warfarin. Cf Thrombolytic.

antithrombotic

1. preventing or interfering with the formation of thrombi.
2. an agent that interferes with thrombus formation. See also antiplatelet drugs.
References in periodicals archive ?
A new analysis of HERS data suggests that statins may have exerted an antithrombotic action that diminished HRT's prothrombotic effect.
In addition, novel antithrombotic targets such as the (thrombin-activatable fibrinolysis inhibitor) TAFIa, plasminogen activator inhibitor-1 (PAI-1) and others were found.
In developed and developing countries, many opportunities for producers and sellers of antithrombotic medicines will occur from 2015 to 2025.
The contract is the purchase of medicines - Antithrombotic for the proper conduct of business within the hospital as - Information about lots.
That study shows the overall market for antithrombotic drugs will expand steadily from 2013 to 2023.
The first 7 days after withdrawal of antiplatelet or antithrombotic medication appeared to be the most dangerous time, Dr.
Antithrombotic agents (B01A) Purchase two (2) years, with a technical description is given in HD in Appendix 1.
Procurement Antithrombotic Drugs Group-Lots-22 Details in the Tender Documentation and Lots
Report Details Antithrombotic agents - discover technological and commercial prospects What does the future hold for treating conditions associated with thrombosis?
A new report by visiongain predicts that the overall world antithrombotic and anticoagulant drug market will reach 24.
ATLANTA -- Comparisons between enoxaparin and fondaparinux were perhaps inevitable when findings from two major clinical trials that evaluated the two different antithrombotic drugs as adjuncts to fibrinolytic therapy for acute MI were reported back-to-back at the annual meeting of the American College of Cardiology.